Taiyo Holdings revises forecast, reports loss, boosts dividend payout

Taiyo Holdings (TSE:4626) announced a revision to its full-year earnings forecast for the fiscal year ending March 31, 2025, the recognition of extraordinary losses, and a revised dividend forecast with a substantial increase. The company will record an impairment loss of ¥7.01 billion related to its sales rights in Taiyo Pharma due to declining profitability, impacting the profit attributable to owners of the parent, which is revised from ¥14.9 billion to ¥10.6 billion. Despite the downward revision of net profits attributable to owners, the company maintains its revenue and operating income forecast.